The Case for RFID: A Pharmaceutical Manufacturer's Perspective
Drug manufacturer Cephalon explains why it is forging ahead with plans to implement RFID and an electronic drug pedigree solution for pharmaceutical products.
Although the California State Board of Pharmacy has delayed implementing its e-pedigree requirement until 2015 and the U.S. Food and Drug Administration won’t release its pedigree plan for another year, drug manufacturer Cephalon is forging ahead with its own plans to implement RFID and an electronic drug pedigree solution for pharmaceutical products.
In the third quarter of 2008, Cephalon began affixing passive ultrahigh-frequency (UHF) RFID tags to cardboard shipping containers and serializing the Electronic Product Code (EPC) numbers on those tags that leave their third-party distribution center in Tennessee.
In this PowerPoint presentation with audio, recorded at RFID JOUrnal LIVE! 2009, Brian Brown, associate director of logistics and analytics at Cephalon, explains how and why the company is moving forward with its implementation plans.
Click on the screen to start the presentation.
In the third quarter of 2008, Cephalon began affixing passive ultrahigh-frequency (UHF) RFID tags to cardboard shipping containers and serializing the Electronic Product Code (EPC) numbers on those tags that leave their third-party distribution center in Tennessee.
In this PowerPoint presentation with audio, recorded at RFID JOUrnal LIVE! 2009, Brian Brown, associate director of logistics and analytics at Cephalon, explains how and why the company is moving forward with its implementation plans.
Click on the screen to start the presentation.
To continue reading this article, please log in or choose a purchase option.
Option 1: Become a Premium Member.
| One-year subscription, unlimited access to Premium Content: $189 |
Option 2: Purchase this article.
| Pages: 1 | Word Count: 206 | Purchase Price: $19.99 |
